The Measurement of Human Plasma Antiplasmin Activity by Radial Diffusion Assay

Summary

An assay of human antiplasmins has been developed utilizing radial diffusion of plasma from wells cut in plasmin-enriched, fibrinogen-agarose plates. After diffusion the fibrinogen is clotted. Zones of fibrin protected from background fibrinolysis develop as the result of plasma antiplasmin activity. A pooled plasma standard was taken to contain 100 % antiplasmin activity. Antiplasmin activity of 52 normal subjects varied from 64 to 132 %. Washed platelets contained 1-5 % antiplasmin activity. Using antisera to precipitate individual inhibitors, physical methods of separation, and electrophoresis of plasma in agarose, several different proteins were found to have antiplasmin activity in this assay. Thus, α₂-macroglobulin contributed 56%, α₁-antitrypsin 20%, antithrombin III 2%, and other proteins 22% of the total antiplasmin activity. 1 ml of whole plasma neutralized 7.0 CTA units of plasmin.

• References

• 1 Andes WA, Lindberg RB, Mceuen DD, Baron JP. 1976; Inhibition of fibrinolysis in the burned infected rat: antiplasmin induced by burn wound infection. Thrombosis and Haemostasis 36: 173
• 2 Cooper KE. 1963. The theory of antibiotic inhibition zones. In: Kavangh F. (Ed.) Analytical Microbiology. Academic Press; London:
• 3 Gallimore MJ. 1975; Serum inhibitors of fibrinolysis. British Journal of Haematology 31: 217
• 4 GALLUS AS, Hirsh J, Gent M. 1973; Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis. Lancet II: 805
• 5 Harpel PC, Mosesson MW. 1973; Degradation of human fibrinogen by plasma α-₂-macro-globulin-enzyme complexes. Journal of Clinical Investigation 52: 2175
• 6 Hedner U. 1973; Studies on an inhibitor of plasminogen activation in human serum. Thrombosis et Diathesis Haemorrhagica 30: 414
• 7 Hedner U. 1974. Thrombosis: Pathogenesis and clinical trials. In: Deutsch E, Brinkhous KM, Lechner K, Hinnon S. Transactions of the plenary sessions, IV International Congress on Thrombosis and Haemostasis; New York:
• 8 Hedner U, Collen D. 1976; Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma. Thrombosis Research 8: 875
• 9 Highsmith RF, Rosenberg RD. 1974; The inhibition of human plasmin by human antithrombin-heparin cofactor. Journal of Biological Chemistry 249: 4335
• 10 Jacobsen CD. 1964; The caseinolytic method for determination of plasminogen-plasmin in human plasma and serum. Scandinavian Journal of Clinical and Laboratory Investigation 16: 372
• 11 Kaelin AC. 1975; Sodium periodate modification of factor VIII procoagulant activity. British Journal of Haematology 31: 349
• 12 Kirkwood TBL, Campbell PJ, Gaffney PJ. 1975; A standard for human plasmin. Thrombosis et Diathesis Haemorrhagica 34: 20
• 13 Lane JL, Bird P, Rizza CR. 1975; A new assay for the measurement of total progressive antithrombin. British Journal of Haematology 30: 103
• 14 Laurell CB. 1972; Electroimmunoassay. Scandinavian Journal of Clinical and Laboratory Investigation 29 Suppl (Suppl. 124) 2
• 15 Miller-Andersson M, Borg H, Andersson LO. 1974; Purification of antithrombin III by affinity chromatography. Thrombosis Research 5: 439
• 16 Murray J, Crawford GPM, Ogston D, Douglas AS. 1974; Studies on an inhibitor of plasminogen activators in human platelets. British Journal of Haematology 26: 661
• 17 Naeye RL. 1961; Thrombotic disorders with increased levels of antiplasmin and antiplasminogen. New England Journal of Medicine 265: 867
• 18 Niléhn JE, Ganrot PO. 1967; Plasmin, plasmiri inhibitors and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase. Scandinavian Journal of Clinical and Laboratory Investigation 20: 113
• 19 Norman PS, Hill BM. 1958; Studies of the plasmin system. III. Physical properties of two plasmin inhibitors. Journal of Experimental Medicine 108: 639
• 20 Pizzo SU, Schwartz ML, Hill RL, Mckee PA. 1972; Mechanism of ancrod anticoagulation: A direct proteolytic effect on fibrin. Journal of Clinical Investigation 51: 2841
• 21 Schmer G, Krys J. 1974; A solid-phase radioassay for plasminogen in human plasma. Journal of Laboratory and Clinical Medicine 83: 153
• 22 Schmer G, Branson HE. 1975; A solid-phase radioassay for the quantitative determination of antiplasmin activity in human plasma. British Journal of Haematology 30: 117
• 23 Sgouris JT, Inman JK, Mccall KB, Hyndman LA, Anderson HD. 1960; The preparation of human fibrinolysin (Plasmin). Vox Sanguinis 5: 357
• 24 WALSH PN. 1972; Albumin Density Gradient Separation and Washing of Platelets and the Study of Platelet Coagulant Activities. British Journal of Haematology 22: 205
• 25 Wiman B, Wallen P. 1973; Activation of human plasminogen by an insoluble derivative of urokinase. European Journal of Biochemistry 36: 25